Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Long-Term Deferred Tax (2016 - 2024)

Historic Long-Term Deferred Tax for Fresenius Medical Care AG (FMS) over the last 16 years, with Q4 2024 value amounting to $245.3 million.

  • Fresenius Medical Care AG's Long-Term Deferred Tax fell 1972.53% to $245.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $245.3 million, marking a year-over-year decrease of 1972.53%. This contributed to the annual value of $245.3 million for FY2024, which is 1972.53% down from last year.
  • Per Fresenius Medical Care AG's latest filing, its Long-Term Deferred Tax stood at $245.3 million for Q4 2024, which was down 1972.53% from $305.5 million recorded in Q4 2023.
  • Fresenius Medical Care AG's 5-year Long-Term Deferred Tax high stood at $418.7 million for Q4 2020, and its period low was $245.3 million during Q4 2024.
  • Over the past 5 years, Fresenius Medical Care AG's median Long-Term Deferred Tax value was $319.0 million (recorded in 2022), while the average stood at $329.8 million.
  • In the last 5 years, Fresenius Medical Care AG's Long-Term Deferred Tax surged by 472.02% in 2020 and then crashed by 1972.53% in 2024.
  • Fresenius Medical Care AG's Long-Term Deferred Tax (Quarter) stood at $418.7 million in 2020, then dropped by 13.83% to $360.8 million in 2021, then dropped by 11.57% to $319.0 million in 2022, then fell by 4.23% to $305.5 million in 2023, then decreased by 19.73% to $245.3 million in 2024.
  • Its last three reported values are $245.3 million in Q4 2024, $305.5 million for Q4 2023, and $319.0 million during Q4 2022.